Ross' Gold Press Release (GHIL):
Ross’ Gold Outlines Business Model as It Enters Medical Marijuana Industry in Canada
Toronto, ON – Date Here – Green and Hill Industries (OTC GHIL) dba Ross’ Gold (the “Company”) has signed an agreement to distribute medical marijuana through a joint-venture partnership (the “JV”) with a private company based in Toronto who will be buying directly from government approved growers under the new model. The JV currently has an application with Health Canada to become an approved licensed producer/distributor and is building a distribution center in Ontario, complete with a vault and all of the security as required by regulations.
Through the partner JV, Ross’ Gold has signed contracts and Letters of intent with growers that have applications proceeding with Health Canada for licensed producer status. These ‘partner growers’ are will be growing strains of medical marijuana which are being branded Ross’ Platinum, Ross’ Gold, Ross’ Silver and Ross’ Bronze based on the levels of tetrahydrocannabinol (THC, a psychoactive constituent of cannabis) and cannabidiol (CBD, another constituent believed to be more medical and less psychoactive).
Due to the sensitivity of the applications with Health Canada and the competitiveness of the industry, the company will not be releasing any names of our partner growers nor the partner JV until they receive their licenses from Health Canada.
Partner growers will be tasked to grow the strains that we have chosen from their existing inventories, and the Ross’ Gold mandate is to create demand through branding in conjunction with our JV partnership. For growers without seeds/clones, the JV supplies proprietary clones from a contracted nursery. The growers take the clones at 8 weeks and grow them through harvest at about 16 weeks where the JV purchases the ‘finished’ product.
For partner growers with seeds/clones/plants now, the JV purchases the finished product directly.
In conjunction, we have contracted with botanists who are developing strains called Ross’ Gold Sour White Widow and Ross’ Gold BC God Bud.
As Ross’ Gold is not a licensed producer, it is able to market itself and its brand through mainstream media and advertising channels providing it does not directly advertise medical marijuana. All licensed producers under Health Canada regulations may be listed on the official Health Canada website, and are extremely limited to doing any promotion or advertising as per section 2 of the Narcotic Control Regulations in Canada, Section 70 whereby “No person shall publish or cause to be published or furnish any advertisement to the general public respecting a narcotic”. “Advertisement” means any representation by any means whatever for the purpose of promoting directly or indirectly the sale or disposal of a narcotic.”
Ross’ Gold has developed its proprietary branding and will be executing a marketing plan, thereby becoming a medical marijuana ‘brand’ without directly advertising a narcotic. Already, the term Ross’ Gold has been used in the media to denote a brand of medical marijuana as well as marijuana in general.
Ross Rebagliati, CEO of Ross’ Gold commented, “With our partnerships, we intend to become the Amazon of Medical Marijuana in Canada. Ross’ Gold has the only full vertical market business model in Canada with strong branding and marketing expertise. Our partnerships take the product from seed/clone through to the end patient by leveraging the expertise of our grower partners, our team strengths and the super-brand we have created called Ross’ Gold. We have instant brand-name recognition, talent and a broad base of marijuana users in Canada who have been following our story making us the number one brand in North America.”
About Ross’ Gold
Ross’s Gold plans to license it established brand through partnerships with government approved licensed producers in Canada for medical cannabis strains called Ross’ Platinum, Ross’ Gold, Ross’ Silver and Ross’ Bronze with specific THC/CBD levels for specific ailments. The Company has an established international brand with the celebrity of Olympic Gold Medal winner Ross Rebagliati and also looking to license its brand to other cannabis related companies globally. Please visit www.rossgold.com for more information.
Safe Harbor Statement
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, projections of worldwide sales of Ross’ Gold’s products and global markets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined at http://www.rebagliatigold.com/rebagliatigold/...arbor.html and other periodic reports filed from time-to-time.
Contact:
Media Inquiries
Ross’ Gold
Telephone: 647.478.3603
ir@rossgold.com
Ross’ Gold Outlines Business Model as It Enters Medical Marijuana Industry in Canada
Toronto, ON – Date Here – Green and Hill Industries (OTC GHIL) dba Ross’ Gold (the “Company”) has signed an agreement to distribute medical marijuana through a joint-venture partnership (the “JV”) with a private company based in Toronto who will be buying directly from government approved growers under the new model. The JV currently has an application with Health Canada to become an approved licensed producer/distributor and is building a distribution center in Ontario, complete with a vault and all of the security as required by regulations.
Through the partner JV, Ross’ Gold has signed contracts and Letters of intent with growers that have applications proceeding with Health Canada for licensed producer status. These ‘partner growers’ are will be growing strains of medical marijuana which are being branded Ross’ Platinum, Ross’ Gold, Ross’ Silver and Ross’ Bronze based on the levels of tetrahydrocannabinol (THC, a psychoactive constituent of cannabis) and cannabidiol (CBD, another constituent believed to be more medical and less psychoactive).
Due to the sensitivity of the applications with Health Canada and the competitiveness of the industry, the company will not be releasing any names of our partner growers nor the partner JV until they receive their licenses from Health Canada.
Partner growers will be tasked to grow the strains that we have chosen from their existing inventories, and the Ross’ Gold mandate is to create demand through branding in conjunction with our JV partnership. For growers without seeds/clones, the JV supplies proprietary clones from a contracted nursery. The growers take the clones at 8 weeks and grow them through harvest at about 16 weeks where the JV purchases the ‘finished’ product.
For partner growers with seeds/clones/plants now, the JV purchases the finished product directly.
In conjunction, we have contracted with botanists who are developing strains called Ross’ Gold Sour White Widow and Ross’ Gold BC God Bud.
As Ross’ Gold is not a licensed producer, it is able to market itself and its brand through mainstream media and advertising channels providing it does not directly advertise medical marijuana. All licensed producers under Health Canada regulations may be listed on the official Health Canada website, and are extremely limited to doing any promotion or advertising as per section 2 of the Narcotic Control Regulations in Canada, Section 70 whereby “No person shall publish or cause to be published or furnish any advertisement to the general public respecting a narcotic”. “Advertisement” means any representation by any means whatever for the purpose of promoting directly or indirectly the sale or disposal of a narcotic.”
Ross’ Gold has developed its proprietary branding and will be executing a marketing plan, thereby becoming a medical marijuana ‘brand’ without directly advertising a narcotic. Already, the term Ross’ Gold has been used in the media to denote a brand of medical marijuana as well as marijuana in general.
Ross Rebagliati, CEO of Ross’ Gold commented, “With our partnerships, we intend to become the Amazon of Medical Marijuana in Canada. Ross’ Gold has the only full vertical market business model in Canada with strong branding and marketing expertise. Our partnerships take the product from seed/clone through to the end patient by leveraging the expertise of our grower partners, our team strengths and the super-brand we have created called Ross’ Gold. We have instant brand-name recognition, talent and a broad base of marijuana users in Canada who have been following our story making us the number one brand in North America.”
About Ross’ Gold
Ross’s Gold plans to license it established brand through partnerships with government approved licensed producers in Canada for medical cannabis strains called Ross’ Platinum, Ross’ Gold, Ross’ Silver and Ross’ Bronze with specific THC/CBD levels for specific ailments. The Company has an established international brand with the celebrity of Olympic Gold Medal winner Ross Rebagliati and also looking to license its brand to other cannabis related companies globally. Please visit www.rossgold.com for more information.
Safe Harbor Statement
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, projections of worldwide sales of Ross’ Gold’s products and global markets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined at http://www.rebagliatigold.com/rebagliatigold/...arbor.html and other periodic reports filed from time-to-time.
Contact:
Media Inquiries
Ross’ Gold
Telephone: 647.478.3603
ir@rossgold.com
